{"id":68947,"date":"2024-06-13T09:33:23","date_gmt":"2024-06-13T14:33:23","guid":{"rendered":"https:\/\/www.partnershipagainstcancer.ca\/topics\/breast-indicators-2018-2021\/indicators\/post-screen-cancer-detection-rate\/"},"modified":"2024-06-13T11:53:15","modified_gmt":"2024-06-13T16:53:15","slug":"post-screen-cancer-detection-rate","status":"publish","type":"topics","link":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/post-screen-cancer-detection-rate\/","title":{"rendered":"Taux de d\u00e9tection de cancers post\u00e9rieurement au d\u00e9pistage"},"content":{"rendered":"<p><strong>Pourquoi est-ce important? <\/strong>Cet indicateur donne un aper\u00e7u de la sensibilit\u00e9 du d\u00e9pistage par mammographie et de la durabilit\u00e9 des activit\u00e9s et des efforts de d\u00e9pistage. Les cancers d\u00e9tect\u00e9s post\u00e9rieurement au d\u00e9pistage sont des cancers d\u00e9tect\u00e9s pendant l\u2019intervalle de d\u00e9pistage, c\u2019est-\u00e0-dire entre un d\u00e9pistage syst\u00e9matique par mammographie et le rendez-vous de d\u00e9pistage suivant. Cela peut inclure des cancers qui n\u2019ont pas \u00e9t\u00e9 d\u00e9tect\u00e9s lors du d\u00e9pistage et de nouveaux cancers apparus pendant l\u2019intervalle de d\u00e9pistage. Avoir un faible taux de cancers d\u00e9tect\u00e9s post\u00e9rieurement au d\u00e9pistage est id\u00e9al si l\u2019on veut que les programmes de d\u00e9pistage r\u00e9ussissent \u00e0 atteindre la r\u00e9duction attendue de la mortalit\u00e9 par cancer du sein.<\/p>\n<p><strong>D\u00e9finition de l\u2019indicateur<\/strong>\u00a0: Nombre de cancers du sein (CCIS et infiltrants) d\u00e9tect\u00e9s apr\u00e8s un \u00e9pisode de d\u00e9pistage du cancer du sein ayant donn\u00e9 des r\u00e9sultats normaux ou de tumeurs b\u00e9nignes (non canc\u00e9reuses) pour\u00a010\u00a0000\u00a0d\u00e9pistages.<\/p>\n<p><strong>Cible<\/strong>\u00a0: Pas de cible<\/p>\n<p><strong>P\u00e9riode de mesure\u00a0<\/strong>: Les ann\u00e9es de d\u00e9pistage du\u00a01<sup>er<\/sup>\u00a0janvier\u00a02017 au\u00a031\u00a0d\u00e9cembre\u00a02018 sont utilis\u00e9es pour cet indicateur, afin de laisser suffisamment de temps pour le suivi et le diagnostic.<\/p>\n<p><strong>Calcul de l\u2019indicateur <\/strong>:<\/p>\n<ul>\n<li>Num\u00e9rateur\u00a0: Nombre de cancers du sein infiltrants ou de CCIS d\u00e9tect\u00e9s dans chacun des intervalles de suivi (0\u00a0\u00e0\u00a012\u00a0mois, &gt;\u00a012\u00a0mois \u00e0\u00a024\u00a0mois et &gt;\u00a024\u00a0mois \u00e0\u00a036\u00a0mois)<\/li>\n<li>D\u00e9nominateur\u00a0: Nombre de mammographies de d\u00e9pistage avec des r\u00e9sultats normaux ou de tumeurs b\u00e9nignes au cours de la p\u00e9riode de mesure<\/li>\n<\/ul>\n<p><strong>Autres consid\u00e9rations\u00a0<\/strong>: L\u2019interpr\u00e9tation de cet indicateur d\u00e9pend de facteurs comme le taux de rappel pour anomalie, l\u2019intervalle de d\u00e9pistage recommand\u00e9, le taux d\u2019incidence sous-jacent, l\u2019\u00e2ge, le d\u00e9pistage opportuniste et l\u2019intervalle diagnostique.<br \/>\n<a name=\"post\"><\/a><\/p>\n<h3>Taux de cancers du sein diagnostiqu\u00e9s post\u00e9rieurement au d\u00e9pistage (pour 10\u00a0000\u00a0d\u00e9pistages) chez les personnes \u00e2g\u00e9es de 50\u00a0\u00e0\u00a074\u00a0ans ayant subi un d\u00e9pistage dans le cadre d\u2019un programme de d\u00e9pistage par mammographie, par territoire de comp\u00e9tence \u2013 ann\u00e9e de d\u00e9pistage 2017-2018<\/h3>\n<p><link rel='stylesheet' href='https:\/\/cdnjs.cloudflare.com\/ajax\/libs\/font-awesome\/4.7.0\/css\/font-awesome.min.css'><link rel='stylesheet' href='https:\/\/www.partnershipagainstcancer.ca\/wp-content\/plugins\/cpac-toolbox\/cpac-toolbox.css?v2'><script type='text\/javascript' src='https:\/\/www.partnershipagainstcancer.ca\/wp-content\/plugins\/cpac-toolbox\/cpac-toolbox.js?v2'><\/script><style>\niframe.cpac-dashboard { .statusBar{display:none;}\r\npbi-status-bar{opacity:0.1;background: white;height: 0;}\r\n.backgroundContainer.outspaceContainer{background:#fff!important;} }\n<\/style><div class='cpac-dashboard-container'><iframe allowfullscreen='allowfullscreen' title='cpac-dashboard-eyJrIjoiNzdkYjZjOTgtMDU2Ny00MDhhLTgxOGEtMDM1MzE4YjAxODU4IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_258' id='dashboard-eyJrIjoiNzdkYjZjOTgtMDU2Ny00MDhhLTgxOGEtMDM1MzE4YjAxODU4IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_258' src='https:\/\/dashboard.cpacc.ca\/report\/eyJrIjoiNzdkYjZjOTgtMDU2Ny00MDhhLTgxOGEtMDM1MzE4YjAxODU4IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9&language=fr-CA' class='cpac-dashboard'  style='width:100%'><\/iframe><\/div><script>\n                    var is_fullreport = 0;\n                    var scrolled = false;\n                    window.addEventListener('message', function(e){\n                            var this_frame = document.getElementById('dashboard-eyJrIjoiNzdkYjZjOTgtMDU2Ny00MDhhLTgxOGEtMDM1MzE4YjAxODU4IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_258');\n\n\t\t\t            \/\/ Extract token from parent src\n    \t\t\t        var parentToken = this_frame.src.split('\/').pop();\n\t\t\t\tparentToken = parentToken.split('&')[0];\n\n\/\/                            console.log(JSON.stringify(e.data));\n                    \tif (e.data && e.data.hasOwnProperty('cpac_height') && \n                            e.data.hasOwnProperty('iframe_token') && \n                            e.data.iframe_token === parentToken && \n                            e.origin == 'https:\/\/dashboard.cpacc.ca') { \n                            \n                            console.log('cpac-dashboard: resizing iframe height to ' + e.data.cpac_height + ' for id=dashboard-eyJrIjoiNzdkYjZjOTgtMDU2Ny00MDhhLTgxOGEtMDM1MzE4YjAxODU4IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_258[' + e.origin + ']' );\n\/\/                                this_frame.height = e.data.cpac_height + 'px';\n                            \n                            if(is_fullreport){\n                                this_frame.style.height = e.data.cpac_height + 'px';\n                            }else if(e.data.cpac_height>200 && e.data.cpac_height<1000){\n                                \/\/ if height = 401px then style.height = 410px\n                                \/\/ if height = 373px then style.height = 380px\n                                \/\/ if height = 350px then style.height = 350px\n                                const cpac_height = (parseInt(e.data.cpac_height\/10)+((e.data.cpac_height%10>0)?1:0))*10;\n                                this_frame.style.height = cpac_height + 'px';\n                            }else{\n                                this_frame.style.height = '500px';\n                            }\n                        }\n\n                            if (e.data && e.data.hasOwnProperty('target_element_y') && e.origin == 'https:\/\/dashboard.cpacc.ca' && !scrolled) {\n                                console.log('received element >>>'+e.data.target_element_y);\n                                let targetYFromDoc = 0;\n                                let element = document.getElementById('dashboard-eyJrIjoiNzdkYjZjOTgtMDU2Ny00MDhhLTgxOGEtMDM1MzE4YjAxODU4IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_258');\n                                while(element){\n                                    targetYFromDoc += parseInt(element.offsetTop - element.scrollTop + element.clientTop);\n                                    element = element.offsetParent;\n                                }\n                                targetYFromDoc += parseInt(e.data.target_element_y?e.data.target_element_y:0);\n                                window.scrollTo({top: targetYFromDoc, behavior: 'smooth'});\n                                scrolled = true;\n                            }\n                        });\n                        var frame_eyJrIjoiNzdkYjZjOTgtMDU2Ny00MDhhLTgxOGEtMDM1MzE4YjAxODU4IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_258 = document.getElementById('dashboard-eyJrIjoiNzdkYjZjOTgtMDU2Ny00MDhhLTgxOGEtMDM1MzE4YjAxODU4IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_258');\n                        frame_eyJrIjoiNzdkYjZjOTgtMDU2Ny00MDhhLTgxOGEtMDM1MzE4YjAxODU4IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_258.onload = function() {\n                            const styleCode = '.statusBar{display:none;}pbi-status-bar{opacity:0.1;background:white;height:0;}.backgroundContainer.outspaceContainer{background:#fff!important;}';\n                            frame_eyJrIjoiNzdkYjZjOTgtMDU2Ny00MDhhLTgxOGEtMDM1MzE4YjAxODU4IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_258.contentWindow.postMessage({'style':styleCode ,'value':'sendStyle'},'*');\n                            const targetId = 'null';\n                            frame_eyJrIjoiNzdkYjZjOTgtMDU2Ny00MDhhLTgxOGEtMDM1MzE4YjAxODU4IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_258.contentWindow.postMessage({'targetId':targetId,'value':'requestTargetPosition'},'*');\n                            const selectBoxId = 'null';\n                            const selectBoxValue = '1';\n                            frame_eyJrIjoiNzdkYjZjOTgtMDU2Ny00MDhhLTgxOGEtMDM1MzE4YjAxODU4IiwidCI6ImQxODkwM2ZiLTk2OTMtNDMyZC1iMDA0LTI3M2I3MDE1NDQ5MCJ9_258.contentWindow.postMessage({'selectBoxId':selectBoxId,'selectBoxValue':selectBoxValue,'value':'requestTargetSelectBoxTrigger'},'*');\n                        };\n                    <\/script><br \/>\n<sub>Man., N.-B. et \u00ce.-P.-\u00c9 : Les donn\u00e9es sur le CCIS et le cancer du sein infiltrant ont \u00e9t\u00e9 combin\u00e9es pour \u00e9viter la divulgation r\u00e9siduelle de petits nombres.<\/sub><br \/>\n<a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/data-tables-breast-indicators\/#post\"><sub>Tableau de donn\u00e9es et notes de bas de page<\/sub><\/a><\/p>\n<p>Les taux de cancers du sein d\u00e9tect\u00e9s post\u00e9rieurement au d\u00e9pistage pour les CCIS et les cancers infiltrants ont \u00e9t\u00e9 combin\u00e9s pour le Manitoba, le Nouveau-Brunswick et l\u2019\u00cele-du-Prince-\u00c9douard, mais non pour la Colombie-Britannique et l\u2019Ontario.<\/p>\n<p>Au Manitoba, au Nouveau-Brunswick et \u00e0 l\u2019\u00cele-du-Prince-\u00c9douard, le taux de d\u00e9tection de cancers post\u00e9rieurement au d\u00e9pistage le plus \u00e9lev\u00e9 a \u00e9t\u00e9 observ\u00e9 au cours de l\u2019intervalle de suivi &gt;\u00a012\u00a0mois \u00e0\u00a024\u00a0mois, allant de\u00a08,2\u00a0pour\u00a010\u00a0000\u00a0d\u00e9pistages \u00e0\u00a011,5 pour\u00a010\u00a0000\u00a0d\u00e9pistages.<\/p>\n<p>En Colombie-Britannique et en Ontario, le taux de cancers infiltrants d\u00e9tect\u00e9s post\u00e9rieurement au d\u00e9pistage \u00e9tait sup\u00e9rieur \u00e0 celui des CCIS dans tous les intervalles de suivi. Le taux de cancers infiltrants d\u00e9tect\u00e9s post\u00e9rieurement au d\u00e9pistage en Colombie-Britannique et en Ontario pour l\u2019intervalle de suivi &gt;\u00a012\u00a0mois \u00e0\u00a024\u00a0mois \u00e9tait respectivement de\u00a08,3 et\u00a08,6 pour\u00a010\u00a0000\u00a0d\u00e9pistages.<\/p>\n<style>.cpac-dashboard-container {margin-bottom: -60px;}<\/style>\n","protected":false},"excerpt":{"rendered":"<p>Pourquoi est-ce important? Cet indicateur donne un aper\u00e7u de la sensibilit\u00e9 du d\u00e9pistage par mammographie et de la durabilit\u00e9 des activit\u00e9s et des efforts de d\u00e9pistage. Les cancers d\u00e9tect\u00e9s post\u00e9rieurement au d\u00e9pistage sont des cancers d\u00e9tect\u00e9s pendant l\u2019intervalle de d\u00e9pistage, c\u2019est-\u00e0-dire entre un d\u00e9pistage syst\u00e9matique par mammographie et le rendez-vous de d\u00e9pistage suivant. Cela peut [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":0,"parent":68910,"menu_order":6,"template":"","topics_tags":[],"type-of-care":[],"cancer-continuum":[],"cancer-system-measurement":[],"dbt-cancer-site":[],"dbt-risk-factors":[],"dbt-population-characteristics":[],"class_list":["post-68947","topics","type-topics","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Canadian Partnership Against Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/post-screen-cancer-detection-rate\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Taux de d\u00e9tection de cancers post\u00e9rieurement au d\u00e9pistage - Canadian Partnership Against Cancer\" \/>\n<meta property=\"og:description\" content=\"Pourquoi est-ce important? Cet indicateur donne un aper\u00e7u de la sensibilit\u00e9 du d\u00e9pistage par mammographie et de la durabilit\u00e9 des activit\u00e9s et des efforts de d\u00e9pistage. Les cancers d\u00e9tect\u00e9s post\u00e9rieurement au d\u00e9pistage sont des cancers d\u00e9tect\u00e9s pendant l\u2019intervalle de d\u00e9pistage, c\u2019est-\u00e0-dire entre un d\u00e9pistage syst\u00e9matique par mammographie et le rendez-vous de d\u00e9pistage suivant. Cela peut [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/post-screen-cancer-detection-rate\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Partnership Against Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-13T16:53:15+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cancerstratca\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/indicators\\\/post-screen-cancer-detection-rate\\\/\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/indicators\\\/post-screen-cancer-detection-rate\\\/\",\"name\":\"Taux de d\u00e9tection de cancers post\u00e9rieurement au d\u00e9pistage - Canadian Partnership Against Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\"},\"datePublished\":\"2024-06-13T14:33:23+00:00\",\"dateModified\":\"2024-06-13T16:53:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/indicators\\\/post-screen-cancer-detection-rate\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/indicators\\\/post-screen-cancer-detection-rate\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/indicators\\\/post-screen-cancer-detection-rate\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Topics\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/topics\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Surveillance et \u00e9valuation des indicateurs de la qualit\u00e9 du d\u00e9pistage du cancer du sein\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Indicateurs\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/topics\\\/breast-indicators-2018-2021\\\/indicators\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Taux de d\u00e9tection de cancers post\u00e9rieurement au d\u00e9pistage\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\",\"url\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/\",\"name\":\"Canadian Partnership Against Cancer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Partnership Against Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/post-screen-cancer-detection-rate\/","og_locale":"fr_FR","og_type":"article","og_title":"Taux de d\u00e9tection de cancers post\u00e9rieurement au d\u00e9pistage - Canadian Partnership Against Cancer","og_description":"Pourquoi est-ce important? Cet indicateur donne un aper\u00e7u de la sensibilit\u00e9 du d\u00e9pistage par mammographie et de la durabilit\u00e9 des activit\u00e9s et des efforts de d\u00e9pistage. Les cancers d\u00e9tect\u00e9s post\u00e9rieurement au d\u00e9pistage sont des cancers d\u00e9tect\u00e9s pendant l\u2019intervalle de d\u00e9pistage, c\u2019est-\u00e0-dire entre un d\u00e9pistage syst\u00e9matique par mammographie et le rendez-vous de d\u00e9pistage suivant. Cela peut [&hellip;]","og_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/post-screen-cancer-detection-rate\/","og_site_name":"Canadian Partnership Against Cancer","article_publisher":"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/","article_modified_time":"2024-06-13T16:53:15+00:00","twitter_card":"summary_large_image","twitter_site":"@cancerstratca","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/post-screen-cancer-detection-rate\/","url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/post-screen-cancer-detection-rate\/","name":"Taux de d\u00e9tection de cancers post\u00e9rieurement au d\u00e9pistage - Canadian Partnership Against Cancer","isPartOf":{"@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website"},"datePublished":"2024-06-13T14:33:23+00:00","dateModified":"2024-06-13T16:53:15+00:00","breadcrumb":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/post-screen-cancer-detection-rate\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/post-screen-cancer-detection-rate\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/post-screen-cancer-detection-rate\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Topics","item":"https:\/\/www.partnershipagainstcancer.ca\/topics\/"},{"@type":"ListItem","position":2,"name":"Surveillance et \u00e9valuation des indicateurs de la qualit\u00e9 du d\u00e9pistage du cancer du sein","item":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/"},{"@type":"ListItem","position":3,"name":"Indicateurs","item":"https:\/\/www.partnershipagainstcancer.ca\/fr\/topics\/breast-indicators-2018-2021\/indicators\/"},{"@type":"ListItem","position":4,"name":"Taux de d\u00e9tection de cancers post\u00e9rieurement au d\u00e9pistage"}]},{"@type":"WebSite","@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website","url":"https:\/\/dev.partnershipagainstcancer.ca\/","name":"Canadian Partnership Against Cancer","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.partnershipagainstcancer.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/68947","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics"}],"about":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/types\/topics"}],"author":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/users\/24"}],"up":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics\/68910"}],"wp:attachment":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=68947"}],"wp:term":[{"taxonomy":"topics_tags","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/topics_tags?post=68947"},{"taxonomy":"type-of-care","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/type-of-care?post=68947"},{"taxonomy":"cancer-continuum","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-continuum?post=68947"},{"taxonomy":"cancer-system-measurement","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/cancer-system-measurement?post=68947"},{"taxonomy":"dbt-cancer-site","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-cancer-site?post=68947"},{"taxonomy":"dbt-risk-factors","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-risk-factors?post=68947"},{"taxonomy":"dbt-population-characteristics","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/dbt-population-characteristics?post=68947"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}